Concepedia
Author
Anne‐Laure Chené
Also Known As
A-L Chene, A-L. Chéné, A. Chene, A.-L. Chéné, A.L. Chene, A.L. Chéné, Anne-Laure Chene, Anne-Laure Chéné, Anne‐Laure Chené, Anne‐Laure Chéné
28
Publications
322
Citations
8
H-Index
9
Concepts
All Affiliations
1
2
105
3
81
4
24
5
×
All Concepts
6
251
Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages
Anne‐Laure Chené, Sènan Mickaël D'Almeida, Thibaut Blondy, +7
Journal of Thoracic Oncology
InflammationMacrophage BiologyPleural EffusionsImmunologyPathology +6
2016
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
Thibaut Blondy, Sènan Mickaël D'Almeida, Tina Briolay, +12
Journal for ImmunoTherapy of Cancer
2020
53
Functional assessment and phenotypic heterogeneity of<i>SFTPA1</i>and<i>SFTPA2</i>mutations in interstitial lung diseases and lung cancer
Marie Legendre, Afifaa Butt, Raphaël Borie, +38
European Respiratory Journal
43
Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia
Naïla Benkalfate, Emmanuel Eschapasse, Thomas Georges, +14
BMJ Open Respiratory Research
2022
30
Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab
Mathilde Bureau, Thierry Chatellier, Tanguy Perennec, +7
Cancer Immunology Immunotherapy
Pd-l1 ≥ 50First-line PembrolizumabOncologyPathologyImmune Checkpoint Inhibitor +5
2021
Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase
Julien Mahé, Emilie Patras de Campaigno, Anne‐Laure Chené, +3
British Journal of Clinical Pharmacology
2018
20
Page 1